OmniaBio | CCRM
Silver
Information
OmniaBio Inc. is a subsidiary of CCRM. OmniaBio’s facility will be Canada’s first and largest commercial-scale CDMO dedicated to cell and gene therapies. Located at McMaster Innovation Park in Hamilton, Ontario, OmniaBio will anchor a biomanufacturing centre of excellence and will open in three phases between 2024 and 2026. Benefitting from CCRM’s existing expertise and established business practices, OmniaBio will complete CCRM’s continuum of process development and manufacturing capabilities by enabling focused support for clients with late clinical phase and commercial supply needs. OmniaBio is supported by the Government of Ontario, via the Invest Ontario Fund. Visit us at omniabio.com.